• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺癌患者放射性肺炎预测模型的验证与优化

Validation and optimization of a predictive model for radiation pneumonitis in patients with lung cancer.

作者信息

Mörth Charlott, Kafantaris Ioannis, Castegren Markus, Valachis Antonios

机构信息

Centre for Clinical Research Sörmland, Uppsala University, SE-631 88 Eskilstuna, Sweden; Department of Oncology, Mälarsjukhuset, SE-631 88 Eskilstuna, Sweden.

Department of Pulmonary Medicine, Mälarsjukhuset, SE-631 88 Eskilstuna, Sweden.

出版信息

Oncol Lett. 2016 Aug;12(2):1144-1148. doi: 10.3892/ol.2016.4678. Epub 2016 Jun 6.

DOI:10.3892/ol.2016.4678
PMID:27446409
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4950220/
Abstract

The aim of the current retrospective study was to validate a predictive model for radiation pneumonitis (STRIPE) in an independent dataset and to investigate whether the addition of other potential risk factors could strengthen the accuracy of the model. Consecutive patients with non-small cell lung carcinoma (NSCLC; n=71) treated with definitive concurrent chemotherapy and radiotherapy were retrospectively assessed for radiation pneumonitis (RP). The results identified that 16 (23%) patients developed grade ≥2 RP. Furthermore, STRIPE score (intermediate vs. low risk) was independently associated with the development of RP [odds ratio (OR), 3.72; 95% confidence interval (CI), 1.00-13.89], whereas current smoking status was found to be protective against RP (OR, 0.09; 95% CI, 0.01-0.78). Similar discriminatory power of the STRIPE score was observed as in the original study. The addition of smoking status strengthened the model's discriminatory ability to predict RP. Thus, the addition of smoking status as a risk factor may strengthen the accuracy of the model for predicting RP in patients with NSCLC.

摘要

本回顾性研究的目的是在一个独立数据集中验证放射性肺炎预测模型(STRIPE),并研究添加其他潜在风险因素是否能提高该模型的准确性。对接受根治性同步放化疗的非小细胞肺癌(NSCLC;n = 71)连续患者进行放射性肺炎(RP)的回顾性评估。结果发现,16例(23%)患者发生≥2级RP。此外,STRIPE评分(中度风险与低风险)与RP的发生独立相关[比值比(OR),3.72;95%置信区间(CI),1.00 - 13.89],而当前吸烟状态对RP具有保护作用(OR,0.09;95% CI,0.01 - 0.78)。观察到STRIPE评分的鉴别能力与原研究相似。添加吸烟状态增强了模型预测RP的鉴别能力。因此,添加吸烟状态作为风险因素可能会提高NSCLC患者RP预测模型的准确性。

相似文献

1
Validation and optimization of a predictive model for radiation pneumonitis in patients with lung cancer.肺癌患者放射性肺炎预测模型的验证与优化
Oncol Lett. 2016 Aug;12(2):1144-1148. doi: 10.3892/ol.2016.4678. Epub 2016 Jun 6.
2
Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.骨形态发生蛋白2/骨形态发生蛋白4(BMP2/BMP4)的多态性以及平均肺剂量估计值,可预测接受非小细胞肺癌根治性放疗患者的放射性肺炎。
Oncotarget. 2017 Jun 27;8(26):43080-43090. doi: 10.18632/oncotarget.17904.
3
Left Ventricular Systolic Dysfunction Is a Possible Independent Risk Factor of Radiation Pneumonitis in Locally Advanced Lung Cancer Patients.左心室收缩功能障碍是局部晚期肺癌患者放射性肺炎的一个可能独立危险因素。
Front Oncol. 2020 Jan 24;9:1511. doi: 10.3389/fonc.2019.01511. eCollection 2019.
4
A study of ethnic differences in TGFβ1 gene polymorphisms and effects on the risk of radiation pneumonitis in non-small-cell lung cancer.一项关于 TGFβ1 基因多态性的种族差异及其对非小细胞肺癌放射性肺炎发病风险影响的研究。
J Thorac Oncol. 2012 Nov;7(11):1668-75. doi: 10.1097/JTO.0b013e318267cf5b.
5
Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.临床和剂量学因素预测非小细胞肺癌术后放疗后≥2 级放射性肺炎。
Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):919-926. doi: 10.1016/j.ijrobp.2018.04.012. Epub 2018 Apr 12.
6
Neutrophil-lymphocyte ratio and a dosimetric factor for predicting symptomatic radiation pneumonitis in non-small-cell lung cancer patients treated with concurrent chemoradiotherapy.中性粒细胞与淋巴细胞比值及一个剂量学因素对接受同步放化疗的非小细胞肺癌患者症状性放射性肺炎的预测作用
Clin Respir J. 2018 Mar;12(3):1264-1273. doi: 10.1111/crj.12660. Epub 2017 Jun 28.
7
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.剂量体积直方图参数对预测肺癌同步放化疗后放射性肺炎的预测价值。
Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):110-5. doi: 10.1016/s0360-3016(02)03807-5.
8
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.接受肺癌根治性放化疗患者发生严重放射性肺炎的预测因素。
Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):89-94. doi: 10.1016/s0360-3016(00)00648-9.
9
Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.吸入性类固醇作为放疗后II级放射性肺炎有症状肺癌患者的个体化治疗——单中心经验
Radiat Oncol. 2016 Feb 2;11:12. doi: 10.1186/s13014-016-0580-3.
10
Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.验证有效剂量作为预测放射性肺炎风险的更好指标优于平均肺剂量:一项随机试验的二次分析。
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):403-410. doi: 10.1016/j.ijrobp.2018.09.029. Epub 2018 Oct 3.

引用本文的文献

1
Analysis of the risk factors of radiation pneumonitis in patients after radiotherapy for esophageal squamous cell carcinoma.食管鳞状细胞癌放疗后患者放射性肺炎的危险因素分析
Front Oncol. 2023 Nov 7;13:1198872. doi: 10.3389/fonc.2023.1198872. eCollection 2023.
2
Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis.亚洲与非亚洲局部晚期非小细胞肺癌患者放化疗后肺炎的比较:一项系统评价与荟萃分析
EClinicalMedicine. 2023 Sep 25;64:102246. doi: 10.1016/j.eclinm.2023.102246. eCollection 2023 Oct.
3
Late Sequelae of Radiotherapy—The Effect of Technical and Conceptual Innovations in Radiation Oncology.放疗的晚期后遗症——放射肿瘤学中技术和理念创新的影响。
Dtsch Arztebl Int. 2021 Mar 26;118(12):205-211. doi: 10.3238/arztebl.m2021.0024.
4
Establishment and Verification of a Prediction Model for Symptomatic Radiation Pneumonitis in Patients with Esophageal Cancer Receiving Radiotherapy.建立并验证一个预测模型,用于预测接受放疗的食管癌患者出现症状性放射性肺炎的风险。
Med Sci Monit. 2021 May 6;27:e930515. doi: 10.12659/MSM.930515.
5
Heart V5 predicts cardiac events in unresectable lung cancer patients undergoing chemoradiation.心脏V5可预测接受放化疗的不可切除肺癌患者的心脏事件。
J Thorac Dis. 2019 Jun;11(6):2229-2239. doi: 10.21037/jtd.2019.06.29.

本文引用的文献

1
Combined analysis of V20, VS5, pulmonary fibrosis score on baseline computed tomography, and patient age improves prediction of severe radiation pneumonitis after concurrent chemoradiotherapy for locally advanced non-small-cell lung cancer.联合分析基线 CT 上的 V20、VS5、肺纤维化评分和患者年龄可提高局部晚期非小细胞肺癌同期放化疗后重度放射性肺炎的预测能力。
J Thorac Oncol. 2014 Jul;9(7):983-990. doi: 10.1097/JTO.0000000000000187.
2
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.早期和局部晚期非小细胞肺癌(NSCLC):ESMO临床实践指南之诊断、治疗及随访
Ann Oncol. 2013 Oct;24 Suppl 6:vi89-98. doi: 10.1093/annonc/mdt241. Epub 2013 Jul 16.
3
A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis.基于文献的放射性肺炎发生的临床危险因素的荟萃分析。
Acta Oncol. 2012 Nov;51(8):975-83. doi: 10.3109/0284186X.2012.718093. Epub 2012 Sep 5.
4
Prediction of radiation pneumonitis in lung cancer patients: a systematic review.预测肺癌患者放射性肺炎:系统综述。
J Cancer Res Clin Oncol. 2012 Dec;138(12):2103-16. doi: 10.1007/s00432-012-1284-1. Epub 2012 Jul 29.
5
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.预测肺癌放化疗后放射性肺炎:国际个体患者数据分析荟萃分析。
Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):444-50. doi: 10.1016/j.ijrobp.2012.04.043. Epub 2012 Jun 9.
6
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
7
Concurrent chemoradiotherapy in non-small cell lung cancer.非小细胞肺癌的同步放化疗
Cochrane Database Syst Rev. 2010 Jun 16(6):CD002140. doi: 10.1002/14651858.CD002140.pub3.
8
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.局部晚期非小细胞肺癌同期与序贯放化疗的荟萃分析。
J Clin Oncol. 2010 May 1;28(13):2181-90. doi: 10.1200/JCO.2009.26.2543. Epub 2010 Mar 29.
9
Combined chemo-radiotherapy for locally advanced non-small cell lung cancer: current status and future development.局部晚期非小细胞肺癌的放化疗联合治疗:现状与未来发展
Crit Rev Oncol Hematol. 2008 Dec;68(3):222-32. doi: 10.1016/j.critrevonc.2008.05.007. Epub 2008 Jul 15.
10
The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours.国际肺癌研究协会肺癌分期项目:关于在即将出版的(第七版)《恶性肿瘤TNM分类》中修订TNM分期分组的建议。
J Thorac Oncol. 2007 Aug;2(8):706-14. doi: 10.1097/JTO.0b013e31812f3c1a.